Latest Headlines

A decade and a half after the approval of mifepristone, there is a lot to celebrate, since many U.S. women now have a choice in the type of abortion they can have. But it is also clear that this drug has been treated differently from other medications, resulting in restrictions that have severely limited its potential to improve access to early abortion.

New research from the UCSF Bixby Center is answering important questions about how to make pregnancy safer for women worldwide.

This year marks the 15th anniversary of the U.S. approval of the abortion pill, which is quietly replacing surgery. As Congress debates fetal tissues and late-term abortions, 38 states are restricting use of the pills.

Since the abortion pill was approved 15 years ago, 2 million American women have used it to end a pregnancy, but pro-abortion rights advocates on Tuesday said disparities in access among states – from requiring a doctor to be present to limiting the use of technology – continue to be a problem for women.

Mifepristone has been available to women for 15 years.

Recent developments in the emerging field of multipurpose prevention technologies (MPTs) are poised to deliver a new generation of safe and effective prevention methods that better meet women’s needs.

On this episode of Reality Cast, Amanda Marcotte covers the Planned Parenthood hearing and features Gretchen Sisson on the portrayal of abortion in movies.

By the close of 2011, one in nine hospital beds in this country existed in a Catholic or Catholic-sponsored health-care facility.

The experiences of women who have an unwanted pregnancy and seek an abortion are rarely heard in the conversations happening in the media and in legislative bodies across the country.

A new state law will allow California women to obtain birth control prescribed by a pharmacist. But some doctors and legislators want to go even further -- to make birth control available over the counter, with no prescription required at all.